Latest News and Press Releases
Want to stay updated on the latest news?
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 20, 2016) - Medical information teams have been expanding their duties, such as adding reimbursement assistance, according to a pharmaceutical...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 15, 2016) - A variety of teams contribute to the development and execution of drug manufacturers' drug safety strategies. Out of all functions,...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 14, 2016) - A recent study found that 74% of surveyed drug companies market new products in the US during their first launch wave. During this same...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 13, 2016) - A study published by Cutting Edge Information found that 86% of surveyed pharmaceutical companies do not complete market access...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 01, 2016) - Patient centricity is no longer a buzzword in the pharmaceutical industry. The industry's transition away from brand-focused messages...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 31, 2016) - A new study published by Cutting Edge Information reported that 70% of surveyed pharmaceutical firms employ Phase 4 groups at the global...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 30, 2016) - Pharmaceutical regulatory agencies are requesting greater access to drug companies' trial master files (TMFs). But only half the...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 26, 2016) - As the pharmaceutical industry continues to shrink its sales teams, some companies are working to incorporate their field reps in the...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 24, 2016) - Although pharmaceutical brand teams do not have the final say on their products' launch sequences, they play an active role in ad hoc...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 23, 2016) - Among post-launch pharmacovigilance activities, the number of individual case safety reports (ICSRs) that a drug company receives each...